Announcement under Regulation 30 (LODR)-Investor Presentation

Dear Sir/Madam, Pursuant to Regulation 30(6) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, we are enclosing herewith Investor Presentation on the Company's Financial Performance of Q1FY23. The said presentation will also be made available at the website of the Company at Presentations You are requested to kindly take the same on your record.

about 1 month ago



Sentiments detected

Positive 9
  • Q1 FY23 HIGHLIGHTS Financial Statement Summary CONSOLIDATED REVENUE ₹ IN CRORE (CONSOLIDATED P&L STATEMENT) ₹ IN CRORE 113.3 12 % Q-O-Q PARTICULARS Q1 FY22 Q4 FY22 Q1 FY23 Q-o-Q Y-o-Y Growth in topline driven by higher realization and volumes

  • Revenue from Operations 70.65 101.64 113.39 11.56% 60.50% Total Income 72.46 104.77 114.16 8.96% 57.55% CONSOLIDATED EBITDA ₹ IN CRORE Total Operating Expense 59.67 91.09 98.52 8.16% 65.11% EBITDA (Including OI) 12.79 13.68 15.64 14.33% 22.28% 13.6 14 % Q-O-Q EBITDA Margin % 18.10% 13.46% 13.79% 33 bps (431) bps Growth in absolute EBITDA on back of higher realization and volumes Interest Cost 0.49 1.85 2.29 23.78% 367.35%

  • However, I am pleased to report that we successfully passed on the price rise in the domestic markets, and the prices in the export market will correct sequentially as stated in our contracts.

  • Though higher realisations primarily drove the growth in the top line, we also recorded moderate growth in volumes.

  • While businesses such as IN % pigment and dye intermediates struggled during the quarter, we saw steady demand from other domestic industries.

  • We also had strong traction in speciality chemicals, particularly 40% in export markets, where demand remained robust.

  • With the second phase of our expansion nearing completion, we anticipate FY23 to be a year of strong volumetric growth.

  • This, combined with a weakening commodity price cycle, should help improve our operational performance as our working capital cycles return to normal.

  • However, I'd want to point out that this is a year in which the ramp-up Q1FY23 SALE OF BULK CHEMICALS of bulk chemicals will be faster, resulting in a more significant contribution to the revenue IN % and profitability pie.

Negative 3
  • Q1FY23 SALE OF SPECIALITY While we are approaching optimal capacity utilisation levels in our bulk chemicals plant, CHEMICALS slow domestic demand has resulted in muted volume growth.

  • We also have a one-month maintenance shutdown planned at our Mr. Bimal L Goculdas Roha site in Q3FY23.

  • However with a products to be manufactured downturn in the international and other details remain markets for the product confidential as the company category, the plan has been has signed an NDA put on hold

Mentioned Phrases & Organizations

Important keywords detected (20+)

growth (10)
presentation (9)
investor (7)
crores (7)
dmcc (6)
chemicals (6)
dharamsi (5)
statements (5)
bulk (5)
dahej (5)
information (4)
domestic (4)
invested (4)
production (4)
bulk chemicals (4)
company invested (4)
financial (3)
performance (3)
made (3)
morarji (3)

Organizations identified (8+)

DMCC (1)
PBT (1)
ROHA (1)
NDA (1)

Features are experimental.